Casdin Capital, LLC Revolution Medicines, Inc. Transaction History

Casdin Capital, LLC

$1.29 Billion
Q3 2024

A detailed history of Casdin Capital, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 4,114,283 shares of RVMD stock, worth $232 Million. This represents 14.48% of its overall portfolio holdings.

Number of Shares

4,114,283

Previous 4,406,875 6.64%

Holding current value

$232 Million

Previous $171 Million 9.0%

% of portfolio

14.48%

Previous 14.75%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $10.8 Million - $14 Million	-292,592 Reduced 6.64%	4,114,283 $186 Million
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $36.5 Million - $49.3 Million	-1,210,724 Reduced 21.55%	4,406,875 $171 Million
Q1 2024 May 15, 2024	SELL	$26.56 - $33.55 $2.58 Million - $3.26 Million	-97,176 Reduced 1.7%	5,617,599 $181 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $71.7 Million - $133 Million	3,904,775 Added 215.73%	5,714,775 $164 Million
Q1 2023 May 15, 2023	SELL	$20.76 - $30.09 $14.8 Million - $21.5 Million	-715,000 Reduced 28.32%	1,810,000 $39.2 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $47,736 - $68,931	2,700 Added 0.11%	2,525,000 $60.1 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $2.66 Million - $3.96 Million	152,300 Added 6.43%	2,522,300 $49.7 Million
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $10.5 Million - $14.5 Million	-430,000 Reduced 15.36%	2,370,000 $59.7 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $11.9 Million - $16.5 Million	495,000 Added 21.48%	2,800,000 $77 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $13.4 Million - $21.8 Million	460,465 Added 24.96%	2,305,000 $73.2 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $7.81 Million - $11.4 Million	210,000 Added 12.85%	1,844,535 $84.6 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $34.8 $6.78 Million - $10.4 Million	299,999 Added 22.48%	1,634,535 $56.9 Million
Q2 2020 Aug 14, 2020	BUY	$19.65 - $39.34 $294,750 - $590,100	15,000 Added 1.14%	1,334,536 $42.1 Million
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $26.4 Million - $45 Million	1,319,536 New	1,319,536 $28.9 Million

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.95B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account

Casdin Capital, LLC Revolution Medicines, Inc. Transaction History